These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 23036432)

  • 41. Core temperature correlates with expression of selected stress and immunomodulatory genes in febrile patients with sepsis and noninfectious SIRS.
    Sonna LA; Hawkins L; Lissauer ME; Maldeis P; Towns M; Johnson SB; Moore R; Singh IS; Cowan MJ; Hasday JD
    Cell Stress Chaperones; 2010 Jan; 15(1):55-66. PubMed ID: 19496026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compartmentalization of the inflammatory response in sepsis and SIRS.
    Cavaillon JM; Annane D
    J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sepsis, complement and the dysregulated inflammatory response.
    Ward PA; Gao H
    J Cell Mol Med; 2009 Oct; 13(10):4154-60. PubMed ID: 19725914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers of inflammation in sepsis.
    Takala A; Nupponen I; Kylänpää-Bäck ML; Repo H
    Ann Med; 2002; 34(7-8):614-23. PubMed ID: 12553502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death?
    Terregino CA; Lopez BL; Karras DJ; Killian AJ; Arnold GK
    Ann Emerg Med; 2000 Jan; 35(1):26-34. PubMed ID: 10613937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cellular and molecular changes of the liver in sepsis and in systemic inflammatory response syndrome (SIRS)].
    Romics L; Frendl G; Szabó G
    Orv Hetil; 2003 Mar; 144(11):499-506. PubMed ID: 12731336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of macrophage migration inhibitory factor in systemic inflammatory response and development of sepsis].
    Suslov AP; Konopleva MV; Tret'iakova OIu; Kozhushnyĭ AP
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (5):15-23. PubMed ID: 19004279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phagocytosis-Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention.
    Hortová-Kohoutková M; Tidu F; De Zuani M; Šrámek V; Helán M; Frič J
    Shock; 2020 Nov; 54(5):606-614. PubMed ID: 32516170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional analysis of eicosanoids from white blood cells in sepsis and SIRS.
    Baenkler M; Leykauf M; John S
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():25-33. PubMed ID: 17244952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alarmins: awaiting a clinical response.
    Chan JK; Roth J; Oppenheim JJ; Tracey KJ; Vogl T; Feldmann M; Horwood N; Nanchahal J
    J Clin Invest; 2012 Aug; 122(8):2711-9. PubMed ID: 22850880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of pro-and anti-inflammatory host responses.
    van der Poll T; van Zoelen MAD; Wiersinga WJ
    Contrib Microbiol; 2011; 17():125-136. PubMed ID: 21659750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutrophil paralysis in sepsis.
    Alves-Filho JC; Spiller F; Cunha FQ
    Shock; 2010 Sep; 34 Suppl 1():15-21. PubMed ID: 20714263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.
    Fry DE
    Am Surg; 2012 Jan; 78(1):1-8. PubMed ID: 22273282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).
    Horn KD
    QJM; 1998 Apr; 91(4):265-77. PubMed ID: 9666949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice.
    Unsinger J; McDonough JS; Shultz LD; Ferguson TA; Hotchkiss RS
    J Leukoc Biol; 2009 Aug; 86(2):219-27. PubMed ID: 19369639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Systemic inflammatory response syndrome/sepsis--review and terminology and physiopathology study].
    Salles MJ; Sprovieri SR; Bedrikow R; Pereira AC; Cardenuto SL; Azevedo PR; Silva TM; Golin V
    Rev Assoc Med Bras (1992); 1999; 45(1):86-92. PubMed ID: 10436599
    [No Abstract]   [Full Text] [Related]  

  • 57. Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25.
    Saito K; Wagatsuma T; Toyama H; Ejima Y; Hoshi K; Shibusawa M; Kato M; Kurosawa S
    Tohoku J Exp Med; 2008 Sep; 216(1):61-8. PubMed ID: 18719339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alert cell strategy: mechanisms of inflammatory response and organ protection.
    Hatakeyama N; Matsuda N
    Curr Pharm Des; 2014; 20(36):5766-78. PubMed ID: 25229471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The systemic pro-inflammatory response in sepsis.
    de Jong HK; van der Poll T; Wiersinga WJ
    J Innate Immun; 2010; 2(5):422-30. PubMed ID: 20530955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of severity for systemic inflammatory response syndrome and sepsis].
    Kurihara T; Fujishima S; Aikawa N
    Nihon Rinsho; 2004 Dec; 62(12):2291-5. PubMed ID: 15597798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.